ChemFeeds Site Navigation:
Journal Selection:
Search:

1) 3-Dimensional spatially organized PEG-based hydrogels for an aortic valve co-culture model (Biomaterials) Sunday August 2nd 2015


2) Highly enantioselective and diastereoselective conjugate addition of 5H-oxazol-4-ones to 2-chloroacrylonitrile catalyzed by chiral guanidines (Tetrahedron Letters) Saturday August 1st 2015


3) Nitromethane as a cyanating reagent for the synthesis of thiocyanates (Tetrahedron Letters) Saturday August 1st 2015


4) One-step synthesis of alkyl 2-chloropyrimido[1,2-abenzimidazole-3-carboxylates under catalyst-free: combined experimental and computational studies (Tetrahedron Letters) Saturday August 1st 2015


5) Isochromanone derivatives from the endophytic fungus Fusarium sp. PDB51F5 (Tetrahedron Letters) Saturday August 1st 2015


6) Model studies directed to the synthesis of cucurbitacin I C/D rings (Tetrahedron Letters) Saturday August 1st 2015


7) Model studies on construction of the oxabicyclic [3.3.1 core of the mulberry Diels (Tetrahedron Letters) Saturday August 1st 2015


8) Reactions of cyclopropenethiones and acetylenedicarboxylates: synthesis of substituted thioethers and thiocyclobutanones (Tetrahedron Letters) Saturday August 1st 2015


9) An inverse electron-demand diene-transmissive hetero-Diels (Tetrahedron Letters) Saturday August 1st 2015


10) First report of multiple metal ions containing glass (Tetrahedron Letters) Saturday August 1st 2015


11) Oxidation mechanism of black tea pigment theaflavin by peroxidase (Tetrahedron Letters) Saturday August 1st 2015


12) Hetero-annulation reaction between 2-acylnaphthoquinones and 2-aminobenzothiazoles. A new synthetic route to antiproliferative benzo[gbenzothiazolo[2,3-bquinazoline-7,12-quinones (Tetrahedron Letters) Saturday August 1st 2015


13) Aryl/heteroaryl pentafluorobenzenesulfonates (ArOPFBs): new electrophilic coupling partners for room temperature Suzuki (Tetrahedron Letters) Saturday August 1st 2015


14) Synthesis and biological evaluation of new nucleosides derived from trifluoromethoxy-4-quinolones (Tetrahedron Letters) Saturday August 1st 2015


15) Extended benzodifuran (Tetrahedron Letters) Saturday August 1st 2015


16) Isolation and structure determination of the first example of the azeto[2,3-cquinolizinedione ring system (Tetrahedron Letters) Saturday August 1st 2015


17) Synthesis of new triazolium-based ionic liquids and their use in the Morita (Tetrahedron Letters) Saturday August 1st 2015


18) An unexpected product from the attempted acetal formation of 2,4,6-trihydroxybenzaldehyde (Tetrahedron Letters) Saturday August 1st 2015


19) One-pot two-step facile synthesis of 2,3,5,6-tetrafluorobenzonitrile-containing dithiocarbamic acid esters (Tetrahedron Letters) Saturday August 1st 2015


20) First regioselective iodocyclization reaction of 3-aryl-5-(prop-2-ynylthio)-1H-1,2,4-triazoles (Tetrahedron Letters) Saturday August 1st 2015


21) Exploiting shape, cellular-hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical and biological approaches (Biomaterials) Saturday August 1st 2015


22) The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel (Biomaterials) Friday July 31st 2015


23) Biodegradable, phosphate-containing, dual-gelling macromers for cellular delivery in bone tissue engineering (Biomaterials) Friday July 31st 2015


24) Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation (Biomaterials) Friday July 31st 2015


25) Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone (Biomaterials) Friday July 31st 2015


26) Persistent luminescence nanoprobe for biosensing and lifetime imaging of cell apoptosis via time-resolved fluorescence resonance energy transfer (Biomaterials) Friday July 31st 2015


27) Nanostructured platinum grass enables superior impedance reduction for neural microelectrodes (Biomaterials) Friday July 31st 2015


28) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


29) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


30) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


31) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


32) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


33) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Friday July 31st 2015


34) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


35) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


36) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


37) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


38) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


39) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


40) The effects of cobalt (Biomaterials) Thursday July 30th 2015


41) Macroporous thin membranes for cell transplant in regenerative medicine (Biomaterials) Thursday July 30th 2015


42) 3D printing of layered brain-like structures using peptide modified gellan gum substrates (Biomaterials) Thursday July 30th 2015


43) 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia (Biomaterials) Thursday July 30th 2015


44) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


45) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


46) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


47) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


48) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Thursday July 30th 2015


49) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Wednesday July 29th 2015


50) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Wednesday July 29th 2015


51) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Wednesday July 29th 2015


52) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Wednesday July 29th 2015


53) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


54) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


55) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


56) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


57) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


58) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


59) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


60) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


61) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


62) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


63) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


64) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


65) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


66) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


67) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


68) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


69) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


70) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


71) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


72) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


73) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


74) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Tuesday July 28th 2015


75) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


76) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


77) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


78) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


79) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


80) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


81) Neurotropic growth factors and glycosaminoglycan based matrices to induce dopaminergic tissue formation (Biomaterials) Monday July 27th 2015


82) pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon- (Biomaterials) Monday July 27th 2015


83) Spatio-temporally controlled transfection by quantitative injection (Biomaterials) Monday July 27th 2015


84) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Monday July 27th 2015


85) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


86) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


87) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


88) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


89) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


90) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


91) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


92) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


93) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


94) Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer (Biomaterials) Sunday July 26th 2015


95) CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer (Biomaterials) Sunday July 26th 2015


96) Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells (Biomaterials) Sunday July 26th 2015


97) A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening (Biomaterials) Sunday July 26th 2015


98) Synthesis of 3,3-dichloro-2-oxindoles from isatin-3-p-tosylhydrazones and (dichloroiodo)benzene (Tetrahedron Letters) Saturday July 25th 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()